文献速递妇科产科

早期宫颈癌淋巴结分期后的长期淋巴水肿与生活质量:前瞻性多中心SENTIREC CERVIX研究3年随访

Long-term lymphedema and quality of life following lymph node staging in early cervical cancer: 3-year follow-up in the prospective multicenter SENTIREC CERVIX study.
PubMed 文献 · Am J Obstet Gynecol · 2025-09-15

这项全国前瞻性队列研究纳入早期宫颈癌根治术患者,比较前哨淋巴结活检 alone 与前哨淋巴结活检联合盆腔淋巴结清扫后3年内腿淋巴水肿及生活质量。联合清扫组淋巴水肿评分升高更明显,3个月评分可预测持续性水肿,并与多项生活质量损害相关。

要点

  • 前哨淋巴结活检联合盆腔淋巴结清扫者3年腿淋巴水肿评分升高幅度大于单用前哨淋巴结活检者。
  • 术后3个月腿淋巴水肿评分与12个月评分正相关,可预测持续性水肿。
  • 12个月时报告淋巴水肿与疲乏、疼痛及多维度功能损害相关。

核心结论

  • 宫颈癌患者报告长期腿淋巴水肿,前哨淋巴结活检联合盆腔淋巴结清扫后最明显,单用前哨淋巴结活检后程度较轻。
  • 术后3个月腿淋巴水肿评分可预测持续性水肿,后者与多项生活质量症状和功能恶化显著相关。
  • 研究结果支持创伤更小的手术方式,并可能为共享决策和生存期干预提供信息。

研究设计与样本

  • 全国前瞻性队列研究,纳入2017年至2021年接受根治性手术的早期宫颈癌患者,包括前哨淋巴结活检。
  • 肿瘤>20 mm时行备用盆腔淋巴结清扫。
  • 患者术前及术后3、12、24、36个月完成经验证的患者报告结局问卷。
  • 腿淋巴水肿采用欧洲癌症研究与治疗组织宫颈癌模块QLQ-CX24评估,并补充该组织条目库中8个关于腿、生殖器和腹股沟淋巴水肿的单项条目。
  • 生活质量采用LYMQOL工具及欧洲癌症研究与治疗组织QLQ-C30和QLQ-CX24模块报告。

主要发现

  • 109例单用前哨淋巴结活检者,腿淋巴水肿评分从基线至3、12、36个月的平均差值分别为6(95%CI 2-10)、10(95%CI 5-15)、15(95%CI 7-22)。
  • 77例前哨淋巴结活检联合盆腔淋巴结清扫者,相应时间点平均差值分别为18(95%CI 11-25)、29(95%CI 21-37)、21(95%CI 11-32)。
  • 无论淋巴结切除范围如何,3个月腿淋巴水肿评分与12个月腿淋巴水肿评分呈正相关。
  • 体重指数预测单用前哨淋巴结活检后的腿淋巴水肿,而放化疗与备用盆腔淋巴结清扫后的淋巴水肿相关。
  • 12个月随访时报告淋巴水肿与疲乏、疼痛及躯体、认知、社会、性功能等多个生活质量方面受损相关。

关键数值与推荐

  • 从基线至各随访点的平均差值评分以95%置信区间估计,变化≥8分定义为具有临床重要性。
  • 采用线性回归模型分析术后12个月腿淋巴水肿的预测因素。
  • 在淋巴水肿患者中评估LYMQOL各领域生活质量,并用多元线性回归分析领域趋势。
  • 采用临床重要差异解释指南比较有和无腿淋巴水肿患者的生活质量。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pelvic lymphadenectomy is the gold standard in nodal staging in cervical cancer but increases the risk of leg lymphedema. Sentinel lymph node mapping is a less invasive technique that enables accurate detection of nodal metastases, although evidence confirming its oncologic safety has yet to be established. Knowledge of chronic leg lymphedema and quality of life following pelvic lymphadenectomy or sentinel lymph node mapping is essential for informing treatment and survivorship strategies in women with cervical cancer, but current evidence is limited. OBJECTIVE: This study aimed to evaluate long-term leg lymphedema after sentinel lymph node mapping alone and sentinel lymph node mapping with pelvic lymphadenectomy in women with cervical cancer, and to examine risk factors for leg lymphedema and condition-specific quality of life among patients with leg lymphedema at 12-month follow-up. STUDY DESIGN: This national prospective cohort study included patients with early-stage cervical cancer who underwent radical surgery, including sentinel lymph node mapping (2017-2021). In case of tumors >20 mm, backup pelvic lymphadenectomy was performed. Patients completed validated patient-reported outcome questionnaires before surgery and at 3, 12, 24, and 36 months postoperatively. Leg lymphedema was assessed using the European Organisation for Research and Treatment of Cancer cervix cancer module (QLQ-CX24), supplemented by 8 single items from the European Organisation for Research and Treatment of Cancer item library addressing lymphedema of the legs, genitals, and groin. Quality of life was reported according to the LYMQOL (Lymphoedema Quality of Life) tool and the European Organisation for Research and Treatment of Cancer QLQ-C30 and QLQ-CX24 modules. Mean difference scores from baseline to each follow-up were estimated with 95% confidence intervals, defining a change of ≥8 points as clinically important. Linear regression models were used to examine predictors of leg lymphedema 12 months postoperatively. We evaluated quality of life within LYMQOL domains in patients with lymphedema and analyzed domain trends using multiple linear regression. We compared quality of life between patients with and without leg lymphedema using guidelines for interpretation of clinically important differences. RESULTS: Among 109 women who underwent sentinel lymph node mapping alone, the leg lymphedema mean score differences from baseline to 3, 12, and 36 months were 6 (95% confidence interval, 2-10), 10 (95% confidence interval, 5-15), and 15 (95% confidence interval, 7-22), respectively. At similar time points, 77 women reported substantial leg lymphedema after sentinel lymph node mapping with pelvic lymphadenectomy, with mean score differences of 18 (95% confidence interval, 11-25), 29 (95% confidence interval, 21-37), and 21 (95% confidence interval, 11-32). Three-month leg lymphedema scores were positively associated with leg lymphedema scores at 12 months regardless of the extent of lymph node removal. Body mass index predicted leg lymphedema after sentinel lymph node mapping alone, whereas chemoradiotherapy was associated with lymphedema following backup pelvic lymphadenectomy. Reporting lymphedema at 12-month follow-up was associated with impairment in several quality of life aspects, including fatigue, pain, and physical, cognitive, social, and sexual functioning. CONCLUSION: Patients with cervical cancer reported long-term leg lymphedema, most pronounced after sentinel lymph node mapping with pelvic lymphadenectomy, and to a lesser extent after sentinel lymph node mapping alone. Three-month leg lymphedema score predicted persistent lymphedema, which was significantly associated with deterioration in several quality of life symptoms and functioning. Our findings support less invasive surgical approaches and may inform shared decision-making and survivorship intervention.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Ostenfeld EB, Bjørnholt SM, Sponholtz SE, et al. Long-term lymphedema and quality of life following lymph node staging in early cervical cancer: 3-year follow-up in the prospective multicenter SENTIREC CERVIX study. Am J Obstet Gynecol. 2025. PMID: 40962164. doi:10.1016/j.ajog.2025.09.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。